GlassScriptPhysician profile
Regina L Webber
NPI 1952650400
$3,090.57
in general payments reported to CMS, 2019-2025
25 companies · $629 in 2025
The $629 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $641 · 2022: $1,009 · 2023: $466 · 2024: $345 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $783.57 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $434.98 | 2021-2025 | |
| Organon LLC | $426.41 | 2021-2025 | Nexplanon, Nuvaring |
| Sage Therapeutics, LLC | $271.80 | 2021-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $141.49 | 2021-2023 | |
| Hologic Sales and Service, LLC | $123.32 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $112.27 | 2023-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $99.68 | 2022 | |
| Amgen INC. | $88.84 | 2021-2024 | Evenity, Prolia |
| Avion Pharmaceuticals | $82.26 | 2021-2022 | |
| Radius Health, INC. | $70.61 | 2024-2025 | Tymlos |
| Shield Therapeutics INC | $62.38 | 2024-2025 | |
| Therapeuticsmd, INC. | $58.21 | 2021 | |
| Merck Sharp & Dohme LLC | $48.03 | 2021-2025 | Gardasil 9 |
| Exeltis, USA INC. | $43.65 | 2025 | Slynd |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $43.61 | 2024-2025 | Monoferric |
| Mylan Pharmaceuticals INC. | $33.84 | 2021-2022 | |
| Exact Sciences Corporation | $29.16 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $25.48 | 2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $21.58 | 2022 | |
| Sumitomo Pharma America, INC. | $21.06 | 2025 | Myfembree |
| Pfizer INC. | $17.83 | 2025 | |
| Myovant Sciences INC. | $17.57 | 2021 | |
| Millicent US INC | $17.50 | 2025 | Femlyv |
| Evofem Biosciences, INC. | $15.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Webber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.